Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously announcedImplantable Continuous Blood Glucose Monitor technology could transform lives of
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes announced today that Luis
GlucoTrack, Inc. (NASDAQ:GCTK) ("GlucoTrack" or the "Company"), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, provides, updates on
Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors.
SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading